Sign up for our daily briefing
Make your busy days simpler with Axios AM/PM. Catch up on what's new and why it matters in just 5 minutes.
Stay on top of the latest market trends
Subscribe to Axios Markets for the latest market trends and economic insights. Sign up for free.
Sports news worthy of your time
Binge on the stats and stories that drive the sports world with Axios Sports. Sign up for free.
Tech news worthy of your time
Get our smart take on technology from the Valley and D.C. with Axios Login. Sign up for free.
Get the inside stories
Get an insider's guide to the new White House with Axios Sneak Peek. Sign up for free.
Catch up on coronavirus stories and special reports, curated by Mike Allen everyday
Catch up on coronavirus stories and special reports, curated by Mike Allen everyday
Want a daily digest of the top Denver news?
Get a daily digest of the most important stories affecting your hometown with Axios Denver
Want a daily digest of the top Des Moines news?
Get a daily digest of the most important stories affecting your hometown with Axios Des Moines
Want a daily digest of the top Twin Cities news?
Get a daily digest of the most important stories affecting your hometown with Axios Twin Cities
Want a daily digest of the top Tampa Bay news?
Get a daily digest of the most important stories affecting your hometown with Axios Tampa Bay
Want a daily digest of the top Charlotte news?
Get a daily digest of the most important stories affecting your hometown with Axios Charlotte
Illustration: Eniola Odetunde/Axios
Here’s one thing Wall Street investors can say that other Americans can’t: Things are looking really good.
Why it matters: The backdrop is the worst rate of coronavirus infections since the pandemic began. But that’s no match for a prospective vaccine down the line, which adds to already favorable conditions for investors.
- "Yes, new cases and hospitalizations are soaring, but we are inching closer to ending this pandemic," says Ryan Detrick, chief market strategist at LPL Financial.
What’s going on: Investors continued to pile into most risk assets on Monday, following early trial data showing Moderna’s coronavirus vaccine was 94.5% effective.
- Stocks closed at all-time highs. The Dow cinched a new record for the first time since the pandemic hit. (It’s also closing in on the 30,000 mark.)
- Notably, "stay-at-home" companies didn’t broadly sell off like last week when Pfizer released early vaccine trial results, with companies like Peloton rising yesterday. Some Big Tech stocks also rose.
- Oil prices jumped 3%.
Meanwhile, the yield on the 10-year U.S. Treasury note jumped to 0.91% from 0.89% on Friday. (It jumped more than 10 basis points after the Pfizer news last week).
The good news about vaccine progress adds to the better-than-expected developments that have emerged for Wall Street and corporate America during an unprecedented pandemic. Among them:
- Corporate profits that have surprised to the upside.
- Companies confident enough to resume buybacks and dividend payments. (Costco on Monday said it would pay out a special cash dividend this year.)
- Interest rates that will be lower for longer.
Between the lines: The Fed’s ongoing response to the pandemic has played a massive role in buoying investors.
- What to watch: Wall Street is increasingly betting the Fed will make changes to its bond buying program as soon as its next meeting. Fed officials aren’t exactly swatting off that notion.
- What they’re saying: "The Federal Reserve is committed to using all of our available tools — not just the federal-funds rate and forward guidance, but also large-scale asset purchases — to achieve our dual-mandate goals," Fed vice chair Richard Clarida said in a speech on Monday.
The bottom line: "Our glass half-full outlook is bolstered by benign inflation, low interest rates, improving growth trends of earnings, ongoing monetary and fiscal stimulus policies, and medical progress for COVID-19," analysts at U.S. Bank wrote in a note to clients.